Asonep Articles
Pfizer signs up to $511 million deal for Lpath’s AMD treatment and $134 million accord for Phylogica’s for peptide-based vaccines
21 December 2010
Lpath gets $2 million milestone form Merck KGaA on completing Asonep Ph I study, but rejects opt-in extension
31 March 2010
Showing 1-2 of 2 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
